Thyroid cancer is the most common endocrine malignancy with increasing incidence worldwide. The majority of thyroid cancer cases are well differentiated with favorable outcome. However, undifferentiated thyroid cancers are one of the most lethal human malignancies because of their invasiveness, metastatization and refractoriness even to the most recently developed therapies. In this study we show for the first time a significant hyperactivation of ROCK/HDAC6 pathway in thyroid cancer tissues, and its negative correlation with p53 DNA binding ability. We demonstrate that a small compound, SP600125 (SP), is able to induce cell death selectively in undifferentiated thyroid cancer cell lines by specifically acting on the pathogenic pathways of cancer development. In detail, SP acts on the ROCK/HDAC6 pathway involved in dedifferentiation and invasiveness of undifferentiated human cancers, by restoring its physiological activity level. As main consequence, cancer cell migration is inhibited and, at the same time, cell death is induced through the mitotic catastrophe. Moreover, SP exerts a preferential action on the mutant p53 by increasing its DNA binding ability. In TP53-mutant cells that survive mitotic catastrophe this process results in p21 induction and eventually lead to premature senescence. In conclusion, SP has been proved to be able to simultaneously block cell replication and migration, the two main processes involved in cancer development and dissemination, making it an ideal candidate for developing new drugs against anaplastic thyroid cancer.
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways / E.S. Grassi, V. Vezzoli, I. Negri, Á. Lábadi, L. Fugazzola, G. Vitale, L. Persani. - In: ONCOTARGET. - ISSN 1949-2553. - 6:34(2015 Nov 03), pp. 36383-36399.
|Titolo:||SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways|
GRASSI, ELISA STELLARIA (Primo)
VEZZOLI, VALERIA (Secondo)
VITALE, GIOVANNI (Penultimo)
PERSANI, LUCA (Ultimo)
|Parole Chiave:||ROCK; SP600125; mitotic catastrophe; p53; thyroid cancer|
|Settore Scientifico Disciplinare:||Settore MED/13 - Endocrinologia|
Settore MED/04 - Patologia Generale
Settore MED/06 - Oncologia Medica
|Data di pubblicazione:||3-nov-2015|
|Data ahead of print / Data di stampa:||22-set-2015|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.18632/oncotarget.5799|
|Appare nelle tipologie:||01 - Articolo su periodico|